Recurrent Squamous Cell Carcinoma of the Hypopharynx Completed Phase 1 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0029504 (Recurrent Squamous Cell Carcinoma of the Hypopharynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs